相关实验视频
Updated: Jun 12, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.0K
意大利IBD患者的低最佳疾病控制和促成因素:IBD-PODCAST研究
Emma Calabrese1, Sara Onali2, Angela Variola3
1Gastroenterology Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
概括
近一半的意大利炎症性肠病 (IBD) 患者经历了低于最佳的疾病控制 (SDC). 关键因素包括低质量生活得分和缺乏内镜缓解,强调需要主动管理策略.
科学领域:
- 胃肠病学 胃肠病学
- 内部医学 内部医学
- 临床研究 临床研究
背景情况:
- 低于最佳的疾病控制 (SDC) 是炎症性肠病 (IBD) 的重要关注点.
- 根据STRIDE-II标准对SDC的贡献因素需要进一步阐明.
- 该IBD-PODCAST研究旨在在现实世界中评估SDC.
研究的目的:
- 评估意大利一组炎症性肠病 (IBD) 患者中低于最佳疾病控制 (SDC) 的患病率.
- 确定在克罗恩病 (CD) 和性结肠炎 (UC) 患者中导致SDC的关键因素.
- 评估IBD当前的疾病监测和管理实践.
主要方法:
- 进行了一项非干预性,国际性的多中心真实世界研究 (IBD-PODCAST).
- 分析了220名意大利IBD患者 (≥19年,诊断≥1年) 的数据.
- 使用适应的STRIDE-II标准进行了回顾性图表审查和横截面评估.
主要成果:
- 53.4%的克罗恩病 (CD) 和49.0%的性结肠炎 (UC) 患者表现出SDC.
- 导致SDC的主要贡献者包括短时间炎性肠病问卷得分低,内镜缓解缺乏,以及活跃的肠外表现.
- 通过内镜监测疾病发生在~40%的患者,治疗调整在~50%.
结论:
- 很大一部分意大利IBD患者经历了低于最佳的疾病控制.
- 目前的管理策略可能不足,需要对CD和UC采取更积极的方法.
- 根据这些发现,对优化IBD管理的进一步研究是有必要的.
关键词:
疾病控制 疾病控制IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD IBD管理策略 管理策略红色的旗红色的旗根据STRIDE II标准进行评估.更多相关视频
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
323
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
323
Inflammatory Bowel Disease I: Ulcerative Colitis
151
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
151
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
Inflammatory Bowel Disease II: Crohn's Disease
200
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
200
Chronic Bowel Disorders: Introduction
408
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
408
Irritable Bowel Syndrome I: Introduction
255
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
255

